Literature DB >> 35352624

Metreleptin for the treatment of lipodystrophy: leading the way among novel therapeutics for this unmet clinical need.

Stergios A Polyzos1, Christos S Mantzoros2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35352624     DOI： 10.1080/03007995.2022.2059974

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN： 0300-7995            Impact factor:   2.705


× No keyword cloud information.
  1 in total

1.  A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on.

Authors:  Chrysoula Boutari; Christos S Mantzoros
Journal:  Metabolism       Date:  2022-05-15       Impact factor: 13.934
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.